Arrowstreet Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Arrowstreet Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-705,033	Closed	-$3.07M	–	1983
2021 Q2	$3.07M	Sell	705,033 -200,758	-22%	-$818K	﹤0.01%	1220
2021 Q1	$3.72M	Buy	905,791 +469,611	+108%	+$2.04M	0.01%	1308
2020 Q4	$1.74M	Sell	436,180 -48,953	-10%	-$158K	﹤0.01%	1651
2020 Q3	$1.31M	Buy	485,133 +45,120	+10%	+$125K	﹤0.01%	1734
2020 Q2	$1.21M	Sell	440,013 -32,422	-7%	-$90.5K	﹤0.01%	1694
2020 Q1	$1.11M	Sell	472,435 -196,262	-29%	-$668K	﹤0.01%	1283
2019 Q4	$3.14M	Buy	+668,697	New	+$2.74M	0.01%	986
2017 Q3	–	Sell	-54,000	Closed	-$174K	–	1294
2017 Q2	$174K	Buy	+54,000	New	+$153K	﹤0.01%	1007

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Arrowstreet Capital's ATRS Position: Q3 2021 in Review

Arrowstreet Capital sold out of Antares Pharma, Inc. (ATRS) in Q3 2021, closing a stake of 705,033 shares — an estimated $3.07M sold.

Arrowstreet Capital first reported a position in ATRS in Q2 2017 and held it in 8 quarters. The position peaked at $3.72M in Q1 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

Arrowstreet Capital reported no remaining Antares Pharma, Inc. position as of Q3 2021 after selling out during the quarter.
Arrowstreet Capital sold 705,033 Antares Pharma, Inc. shares in Q3 2021, an estimated $3.07M.
Arrowstreet Capital first reported a position in Antares Pharma, Inc. in Q2 2017 and held it in 8 quarters.
Arrowstreet Capital's Antares Pharma, Inc. position peaked at $3.72M in Q1 2021.
170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Arrowstreet Capital's 13F filing for Q3 2021, filed 12 Nov 2021.